1 | treatment of erectile dysfunction | | | | | | | 16 | 0.94% |
2 | the treatment of erectile | | | | | | | 13 | 0.76% |
3 | for the treatment of | | | | | | | 9 | 0.53% |
4 | is used to treat | | | | | | | 8 | 0.47% |
5 | used in the treatment | | | | | | | 6 | 0.35% |
6 | erection and helps to | | | | | | | 5 | 0.29% |
7 | improves erection and helps | | | | | | | 5 | 0.29% |
8 | men and pulmonary arterial | | | | | | | 5 | 0.29% |
9 | is used in the | | | | | | | 5 | 0.29% |
10 | in the treatment of | | | | | | | 5 | 0.29% |
11 | and helps to achieve | | | | | | | 5 | 0.29% |
12 | erectile dysfunction with premature | | | | | | | 4 | 0.23% |
13 | to achieve a successful | | | | | | | 4 | 0.23% |
14 | dysfunction with premature ejaculation | | | | | | | 4 | 0.23% |
15 | of erectile dysfunction with | | | | | | | 4 | 0.23% |
16 | indicated for the treatment | | | | | | | 4 | 0.23% |
17 | helps to achieve a | | | | | | | 4 | 0.23% |
18 | of erectile dysfunction ed | | | | | | | 3 | 0.18% |
19 | contains sildenafil100 mg and | | | | | | | 3 | 0.18% |
20 | a prescription medication for | | | | | | | 3 | 0.18% |
21 | often the first treatment | | | | | | | 3 | 0.18% |
22 | of erectile dysfunction in | | | | | | | 3 | 0.18% |
23 | erectile dysfunction in men | | | | | | | 3 | 0.18% |
24 | is often the first | | | | | | | 3 | 0.18% |
25 | is a prescription medication | | | | | | | 3 | 0.18% |
26 | which is used to | | | | | | | 3 | 0.18% |
27 | and helps sustain the | | | | | | | 3 | 0.18% |
28 | it prolongs and helps | | | | | | | 3 | 0.18% |
29 | drug which is used | | | | | | | 3 | 0.18% |
30 | a drug which is | | | | | | | 3 | 0.18% |
31 | is a drug which | | | | | | | 3 | 0.18% |
32 | used to treat male | | | | | | | 3 | 0.18% |
33 | dysfunction in men and | | | | | | | 3 | 0.18% |
34 | is indicated for the | | | | | | | 3 | 0.18% |
35 | avana is a drug | | | | | | | 3 | 0.18% |
36 | in men and pulmonary | | | | | | | 3 | 0.18% |
37 | and pulmonary arterial hypertension | | | | | | | 3 | 0.18% |
38 | is one of the | | | | | | | 3 | 0.18% |
39 | dysfunction it prolongs and | | | | | | | 3 | 0.18% |
40 | prolongs and helps sustain | | | | | | | 3 | 0.18% |